These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6324635)

  • 21. Approaches to some biochemical mechanisms of action of tuftsin and analogues.
    Kraus-Berthier L; Ferry G; Combe-Perez V; Visalli M; Remond G; Vincent M; Boutin JA
    Biochem Pharmacol; 1991 May; 41(10):1411-8. PubMed ID: 1850275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the mechanism of the augmentation of the phagocytic capability of phagocytic cells by Tuftsin, substance P, neurotensin, and kentsin and the interrelationship between their receptors.
    Goldman R; Bar-Shavit Z
    Ann N Y Acad Sci; 1983; 419():143-55. PubMed ID: 6201115
    [No Abstract]   [Full Text] [Related]  

  • 23. Tuftsin: its chemistry, biology, and clinical potential.
    Fridkin M; Najjar VA
    Crit Rev Biochem Mol Biol; 1989; 24(1):1-40. PubMed ID: 2667894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The similarity between tuftsin (Thr-Lys-Pro-Arg) receptors and tuftsin antibody: a case of induced molecular mimicry.
    Chaudhuri MK; Konopińska D; Bump NJ; Najjar VA
    Ann N Y Acad Sci; 1983; 419():135-42. PubMed ID: 6324634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tuftsin--physiological and clinical aspects and perspectives of its therapeutic use].
    Miarka J; Polko M; Straszecka J
    Przegl Lek; 1983; 40(7):559-62. PubMed ID: 6356235
    [No Abstract]   [Full Text] [Related]  

  • 26. [Role of Fc receptors of lymphocytes, macrophages and other mammalian cells in immune processes].
    Liampert IM
    Usp Sovrem Biol; 1982; 94(1):67-82. PubMed ID: 6753399
    [No Abstract]   [Full Text] [Related]  

  • 27. Tuftsin-macrophage interaction: specific binding and augmentation of phagocytosis.
    Bar-Shavit Z; Stabinsky Y; Fridkin M; Goldman R
    J Cell Physiol; 1979 Jul; 100(1):55-62. PubMed ID: 381320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A biochemical study of the phagocytic activities of tuftsin and its analogues.
    Hisatsune K; Nozaki S; Ishikawa T; Hayashi M; Nogaki K; Ogawa H
    Ann N Y Acad Sci; 1983; 419():205-13. PubMed ID: 6585169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical aspects of tuftsin deficiency syndrome.
    Najjar VA
    Med Biol; 1981 Jun; 59(3):134-8. PubMed ID: 6895538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunology of infective endocarditis.
    Phair JP; Clarke J
    Prog Cardiovasc Dis; 1979; 22(3):137-44. PubMed ID: 92039
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunopharmacological properties of tuftsin and of some analogues.
    Florentin I; Martinez J; Maral J; Pelletier M; Chung V; Roch-Arveiller M; Bruley-Rosset M; Giroud JP; Winternitz F; Mathé G
    Ann N Y Acad Sci; 1983; 419():177-91. PubMed ID: 6424534
    [No Abstract]   [Full Text] [Related]  

  • 32. Tuftsin analogs and their biological activity.
    Siemion IZ; Konopinska D
    Mol Cell Biochem; 1981 Dec; 41():99-112. PubMed ID: 6799778
    [No Abstract]   [Full Text] [Related]  

  • 33. The biological activity of new tuftsin derivatives--induction of phagocytosis.
    Wardowska A; Dzierzbicka K; Trzonkowski P; Myśliwski A
    Acta Pol Pharm; 2006; 63(5):378-81. PubMed ID: 17357588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticancer activity of tuftsin-derived T peptide in postoperative residual tumors.
    An Y; Li L; Yang D; Jia N; Xu C; Wang Q; Wang S; Yuan S
    Anticancer Drugs; 2014 Sep; 25(8):857-67. PubMed ID: 24714081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuftsin and tuftsin conjugates potentiate immunogenic processes: effects and possible mechanisms.
    Dagan S; Tzehoval E; Fridkin M; Feldman M
    J Biol Response Mod; 1987 Dec; 6(6):625-36. PubMed ID: 3502474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase in the immunogenicity of HIV peptide antigens by chemical linkage to polytuftsin (TKPR40).
    Gokulan K; Khare S; Rao DN
    DNA Cell Biol; 1999 Aug; 18(8):623-30. PubMed ID: 10463058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of synthetic tuftsin and its analogs on the function of granulocytes of children with acute lymphoblastic leukemia.
    Kazanowska B; Steuden W; Bogusławska-Jaworska J; Konopińska D
    Arch Immunol Ther Exp (Warsz); 1987; 35(2):169-73. PubMed ID: 3482149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1-Aminocyclobutanecarboxylic acid derivatives as novel structural elements in bioactive peptides: application to tuftsin analogs.
    Gershonov E; Granoth R; Tzehoval E; Gaoni Y; Fridkin M
    J Med Chem; 1996 Nov; 39(24):4833-43. PubMed ID: 8941397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tuftsin].
    Mücke D
    Allerg Immunol (Leipz); 1984; 30(3):127-38. PubMed ID: 6209973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tuftsin, a natural activator of phagocytic functions including tumoricidal activity.
    Najjar VA; Konopinska D; Chaudhuri MK; Schmidt DE; Linehan L
    Mol Cell Biochem; 1981 Dec; 41():3-12. PubMed ID: 6895774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.